Valuation: Septerna, Inc.

Market Cap 155.69Cr 136.12Cr 125.57Cr 115.43Cr 218.71Cr 15TCr 222.45Cr 1.5TCr 588.2Cr 7.32TCr 584.68Cr 571.87Cr 25TCr P/E 2026 *
-20x
P/E 2027 * -14.2x
Enterprise Value 120.8Cr 105.62Cr 97Cr 90Cr 169.7Cr 12TCr 172.6Cr 1.16TCr 456.39Cr 5.68TCr 453.66Cr 443.71Cr 20TCr EV / Sales 2026 *
15.7x
EV / Sales 2027 * 15.9x
Free-Float
97.17%
Yield 2026 *
-
Yield 2027 * -
1 day-1.22%
1 week-5.92%
Current month+2.25%
1 month-4.95%
3 months+32.07%
6 months+25.07%
Current year+22.83%
1 week 32.33
Extreme 32.33
38.04
1 month 32
Extreme 32
38.04
Current year 22.78
Extreme 22.78
38.04
1 year 10.62
Extreme 10.6161
38.04
3 years 4.17
Extreme 4.17
38.04
5 years 4.17
Extreme 4.17
38.04
10 years 4.17
Extreme 4.17
38.04
Manager TitleAgeSince
Chief Executive Officer 60 01/11/2021
President 58 01/08/2025
Director of Finance/CFO 55 06/01/2025
Director TitleAgeSince
Chairman 50 01/11/2021
Director/Board Member 51 01/01/2024
Director/Board Member 60 01/12/2023
Date Insider Type Main position Quantity % Market Cap.
01/07Fiscal year

Executive/Senior Manager

9,999 0.0222%
29/06Fiscal year

Head of Human Resources

6,534 0.0145%
26/06Free

Director

15,000 0.0333%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-5.92%+193.44% - 155.69Cr
-0.17%+1.47%+3.16%+7.43% 5.04TCr
-0.04%-2.54%+389.16%+595.04% 3.93TCr
+0.25%+2.54%+32.53%-5.60% 3.47TCr
+1.61%+3.30%+15.63%+57.58% 3.41TCr
+1.68%-1.40%+4.23%+27.34% 2.66TCr
+0.56%-3.92% - - 1.65TCr
-0.51%+0.32%+70.67%+115.76% 1.53TCr
+0.43%+3.34%+14.96%+17.98% 1.38TCr
+0.91%+2.09%+16.04%-31.06% 1.29TCr
Average +0.34%-0.72%+82.20%+98.06% 2.45TCr
Weighted average by Cap. +0.45%-0.34%+83.25%+122.84%

Financials

2026 *2027 *
Net sales 7.69Cr 6.72Cr 6.2Cr 5.7Cr 11Cr 740.08Cr 11Cr 74Cr 29Cr 361.73Cr 29Cr 28Cr 1.25TCr 6.58Cr 5.76Cr 5.31Cr 4.88Cr 9.25Cr 633.46Cr 9.41Cr 63Cr 25Cr 309.62Cr 25Cr 24Cr 1.07TCr
Net income -6.89Cr -6.02Cr -5.55Cr -5.1Cr -9.67Cr -662.54Cr -9.84Cr -66Cr -26Cr -323.83Cr -26Cr -25Cr -1.12TCr -12Cr -11Cr -9.88Cr -9.08Cr -17Cr -1.18TCr -17Cr -117.9Cr -46Cr -575.89Cr -46Cr -45Cr -1.98TCr
Net Debt -35Cr -31Cr -28Cr -26Cr -49Cr -3.36TCr -50Cr -335.95Cr -131.82Cr -1.64TCr -131.03Cr -128.16Cr -5.66TCr -51Cr -44Cr -41Cr -38Cr -71Cr -4.89TCr -73Cr -489.57Cr -192.09Cr -2.39TCr -190.94Cr -186.76Cr -8.24TCr
Logo Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Employees
130
Date Price Change Volume
15/26/15 $34.25 -0.85% 1,69,497
14/26/14 $34.54 +0.52% 6,50,791
13/26/13 $34.36 -4.37% 3,94,064
10/26/10 $35.93 -5.05% 3,78,161
09/26/09 $37.84 +3.96% 9,69,517
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
34.54USD
Average target price
45.00USD
Spread / Average Target
+30.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEPN Stock